1/1
2 files

Supplementary Figures – Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

figure
posted on 01.03.2022, 09:35 by Figshare Future Science GroupFigshare Future Science Group, Xi Wang, Wenjing Zhong, Jiarong Yi, Haoming Wu, Xuxiazi Zou, Jikun Feng, Xinjian Huang, Siqi Li

Supplementary Figure 1. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

Survival curves stratified by adjuvant ET regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving OFS+TAM/AI (A,B), TAM (C,D) and AI (E,F)

Supplementary Figure 2. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

Survival curves stratified by adjuvant CT regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving AC (A,B), TC (C,D) and TAC (E,F)

Funding

National Natural Science Foundation of China (Grant No. 81972459 and No. 81772826).

History